Mabtas N 500mg Injection
By Mabtas N
Rx
50ml Injection in a Vial

Composition
Rituximab(500mg)

Manufacturer - Intas Pharmaceuticals Ltd
Chinubhai Centre, Off. Nehru Bridge, Ashram Road, Ahmedabad - 380009. Gujarat. India.

Expires on or after
April, 2026

liver
Mabtas N 500mg Injection should be used with caution in patients with liver disease. It is advisable to consult your doctor before starting treatment with this medication. Patients with active liver disease or a history of viral hepatitis should avoid using Mabtas N 500mg Injection, as it may lead to reactivation of the infection. It is crucial to discuss your liver health with your healthcare provider to ensure the safe use of this injection.

kidney
Mabtas N 500mg Injection is generally safe for individuals with kidney disease. Data indicates that dosage adjustment may not be necessary. Consult your doctor for personalized advice.

alcohol
Caution is recommended when drinking alcohol while using Mabtas N 500mg Injection. It is important to consult your doctor for guidance.

driving
"Mabtas N 500mg Injection effects on driving ability unknown. Avoid driving if you have symptoms affecting focus and reaction time."

pregnancy
Mabtas N 500mg Injection may not be safe during pregnancy. Animal studies suggest potential harm to the developing baby. Your doctor will consider the benefits and risks before prescribing. Please consult your doctor before using this medication during pregnancy.

breastfeeding
Mabtas N 500mg Injection is considered safe during breastfeeding based on limited data. It is unlikely to pose a significant risk to the baby.
Habit Forming | No |
Chemical Class | Monoclonal Antibody |
Therapeutic Class | - |
Action Class | CD 20 Inhibitor |
₹34412
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024